OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
000059$5.0059

North Huajin Chemical Industries Co Ltd

Commodity ChemicalsVerified

North Huajin Chemical Industries Co Ltd exhibits a capital structure with a debt-to-equity ratio of 1.26, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.27 and negative free cash flow of -1.33 billion CNY, suggesting limited capacity to meet short-term obligations without external financing. The price-to-book ratio of 0.83 implies that the company's market value is trading below its book value, potentially signaling undervaluation or underlying financial distress. Profitability metrics reveal significant challenges, with a return on equity of -18.21% and a return on assets of -7.1%, both well below the typical performance of firms in the Commodity Chemicals industry. The company reported a net loss of 1.76 billion CNY and an operating loss of 1.72 billion CNY, reflecting a severe decline in operational efficiency and pricing power. Gross profit of 542 million CNY is insufficient to cover operating expenses, further highlighting the company's financial strain. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to regional economic downturns and regulatory shifts in China. The absence of segment-specific revenue breakdowns limits the ability to assess the performance of individual product lines or geographic regions. Growth prospects appear muted, with no disclosed revenue growth in the most recent period and negative operating and free cash flows. Analysts have assigned a mean price target of 7.60 CNY, suggesting a potential upside of 52% from the current market price of 5.0 CNY. However, the lack of positive earnings and the company's current financial position may constrain near-term growth. The company faces several risk factors, including liquidity constraints and a high debt load. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. The negative net cash position after subtracting total debt further exacerbates the company's financial vulnerability. Recent financial filings and transcripts do not provide additional insights into the company's strategic direction or operational improvements. The absence of disclosed capital allocation plans or R&D initiatives suggests a lack of investment in future growth drivers.

30-day price · 000059-0.35 (-6.5%)
Low$4.99High$5.75Close$5.00As of15 May, 00:00 UTC
Profile
CompanyNorth Huajin Chemical Industries Co Ltd
Ticker000059.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. North Huajin Chemical Industries Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

North Huajin Chemical Industries Co Ltd exhibits a capital structure with a debt-to-equity ratio of 1.26, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.27 and negative free cash flow of -1.33 billion CNY, suggesting limited capacity to meet short-term obligations without external financing. The price-to-book ratio of 0.83 implies that the company's market value is trading below its book value, potentially signaling undervaluation or underlying financial distress. Profitability metrics reveal significant challenges, with a return on equity of -18.21% and a return on assets of -7.1%, both well below the typical performance of firms in the Commodity Chemicals industry. The company reported a net loss of 1.76 billion CNY and an operating loss of 1.72 billion CNY, reflecting a severe decline in operational efficiency and pricing power. Gross profit of 542 million CNY is insufficient to cover operating expenses, further highlighting the company's financial strain. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to regional economic downturns and regulatory shifts in China. The absence of segment-specific revenue breakdowns limits the ability to assess the performance of individual product lines or geographic regions. Growth prospects appear muted, with no disclosed revenue growth in the most recent period and negative operating and free cash flows. Analysts have assigned a mean price target of 7.60 CNY, suggesting a potential upside of 52% from the current market price of 5.0 CNY. However, the lack of positive earnings and the company's current financial position may constrain near-term growth. The company faces several risk factors, including liquidity constraints and a high debt load. The risk assessment indicates a medium liquidity risk and a low dilution risk, with no immediate pressure for equity issuance. The negative net cash position after subtracting total debt further exacerbates the company's financial vulnerability. Recent financial filings and transcripts do not provide additional insights into the company's strategic direction or operational improvements. The absence of disclosed capital allocation plans or R&D initiatives suggests a lack of investment in future growth drivers.
Key takeaways
  • The company is trading at a price-to-book ratio of 0.83, indicating potential undervaluation or financial distress.
  • Return on equity of -18.21% and return on assets of -7.1% highlight severe profitability challenges.
  • The company's liquidity position is medium, with a current ratio of 1.27 and negative free cash flow.
  • Analysts have assigned a mean price target of 7.60 CNY, suggesting a potential upside of 52%.
  • The company's revenue is concentrated in a single business segment, increasing exposure to regional and industry-specific risks.
  • The company faces liquidity constraints and a high debt load, with a debt-to-equity ratio of 1.26.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$41.76B
Gross profit$542.0M
Operating income-$1.72B
Net income-$1.76B
R&D
SG&A
D&A
SBC
Operating cash flow-$2.57B
CapEx-$513.6M
Free cash flow-$1.33B
Total assets$24.83B
Total liabilities$15.15B
Total equity$9.68B
Cash & equivalents
Long-term debt$12.20B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$41.76B-$1.72B-$1.76B-$1.33B
FY-1$34.60B-$2.91B-$2.79B-$2.97B
FY-2$46.14B$105.5M$70.3M$799.9M
FY-3$49.06B$794.4M$528.8M$1.28B
FY-4$38.65B$1.14B$942.4M$1.21B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$24.83B$9.68B
FY-1$28.07B$11.48B
FY-2$31.89B$14.29B
FY-3$32.63B$14.43B
FY-4$33.08B$14.33B
PeriodOCFCapExFCFSBC
FY0-$2.57B-$513.6M-$1.33B
FY-1$459.7M-$977.1M-$2.97B
FY-2$970.2M-$317.9M$799.9M
FY-3$1.75B-$205.2M$1.28B
FY-4$2.94B-$670.1M$1.21B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$8.37B$96.4M$44.4M
FQ-1
FQ-2$10.19B-$405.6M-$404.5M
FQ-3$10.94B-$634.7M-$647.2M
FQ-4$9.16B-$293.7M-$342.0M
FQ-5$10.10B-$924.7M-$905.5M
FQ-6$3.34B-$1.26B-$1.15B
FQ-7$11.71B-$211.2M-$241.8M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$26.57B$9.75B$4.45B
FQ-1$24.83B$9.68B
FQ-2$24.47B$10.08B$3.33B
FQ-3$27.37B$10.48B
FQ-4$28.49B$11.15B$4.57B
FQ-5$28.07B$11.48B
FQ-6$27.25B$12.41B$4.90B
FQ-7$28.20B$13.55B
PeriodOCFCapExFCFSBC
FQ0-$1.39B-$40.5M
FQ-1-$2.57B-$513.6M
FQ-2-$3.80B-$319.4M
FQ-3-$3.04B-$245.1M
FQ-4-$5.52B-$146.3M
FQ-5$459.7M-$977.1M
FQ-6-$3.42B-$445.2M
FQ-7-$3.05B-$92.1M
Valuation
Market price$5.00
Market cap$8.00B
Enterprise value$20.20B
P/E
Reported non-GAAP P/E
EV/Revenue0.5
EV/Op income
EV/OCF
P/B0.8
P/Tangible book0.8
Tangible book$9.68B
Net cash-$12.20B
Current ratio1.3
Debt/Equity1.3
ROA-7.1%
ROE-18.2%
Cash conversion1.5%
CapEx/Revenue-1.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000059Activity
Op margin-4.1%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-4.2%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin1.3%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity126.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target7.60 CNY
Median price target7.60 CNY
High price target7.60 CNY
Low price target7.60 CNY
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.14 CNY
Last actual EPS-1.10 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 02:23 UTCJob: 669c20fc